DexCom Inc.
DXCM | NASDAQ
$84.27
+$1.98 (+2.41%)
Nov 2, 2026, 12:16 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 31.01 | 53.27 | 86.17 | 128.68 | 239.71 | 70.56 |
PEG Ratio | 0.67 | 38.35 | 1.35 | 2.25 | -4.19 | 0.19 |
PS Ratio | 5.56 | 7.80 | 13.22 | 15.15 | 21.21 | 18.11 |
PB Ratio | 9.43 | 14.97 | 23.16 | 20.68 | 25.43 | 19.11 |
P/FCF Ratio | 24.04 | 49.89 | 93.57 | 144.72 | 974.44 | 126.18 |
P/OCF Ratio | 17.98 | 31.80 | 63.99 | 65.86 | 117.37 | 73.38 |
OCF/S Ratio | 30.90 | 24.54 | 20.66 | 23.01 | 18.07 | 24.68 |
Debt / Equity Ratio | 0.51 | 1.23 | 1.25 | 1.01 | 1.06 | 1.01 |
Quick Ratio | 1.59 | 1.28 | 2.48 | 1.83 | 4.62 | 5.19 |
Current Ratio | 1.88 | 1.47 | 2.84 | 1.99 | 5.11 | 5.58 |
Asset Turnover | 0.74 | 0.62 | 0.58 | 0.54 | 0.50 | 0.45 |
Interest Coverage | 49.83 | 31.58 | 29.44 | 21.03 | 14.14 | 3.54 |
Return on Equity | 30.46% | 27.40% | 26.18% | 16.01% | 10.62% | 27.02% |
Return on Assets | 13.19% | 8.89% | 8.64% | 6.33% | 4.40% | 11.50% |
Return on Invested Capital | 16.61% | 10.20% | 9.63% | 7.86% | 5.30% | 8.11% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 60.10% | 60.46% | 63.19% | 64.72% | 68.63% | 66.44% |
Net Profit Margin | 17.94% | 14.29% | 14.95% | 11.73% | 8.86% | 25.62% |
Pretax Profit Margin | 23.35% | 17.58% | 19.61% | 13.43% | 10.49% | 11.68% |
Operating Profit Margin | 19.56% | 14.88% | 16.50% | 13.44% | 10.86% | 15.54% |
FCF Margin | 23.11% | 15.64% | 14.13% | 10.47% | 2.18% | 14.36% |
EBITDA Margin | 29.14% | 23.45% | 25.31% | 19.43% | 15.42% | 19.56% |
Add to Watchlist
Select watchlists to add or remove DXCM